Selank vs Semax: Comparing the Nootropic Research Peptides

Selank and Semax are two short synthetic peptides that emerged from Russian pharmacological research and are often grouped together as nootropic research compounds. They share a similar size, a similar delivery route in study settings, and a common design strategy of attaching a stabilizing tail to a naturally occurring peptide motif. Their biological starting points, however, are quite different: one is built from an immune peptide, the other from a fragment of a stress hormone. This overview contrasts their origins, sequences, and the research questions each has been used to explore.

A shared design logic

Both molecules are heptapeptides, meaning seven amino acid residues, and both were engineered by adding a Pro-Gly-Pro terminal sequence to a shorter parent motif. Native regulatory peptides are frequently degraded within seconds by peptidases in plasma and tissue. The added proline-rich tail slows that enzymatic breakdown, which is one reason these analogs have been studied in intranasal form. That route lets a comparatively fragile peptide reach nervous-system targets while bypassing first-pass metabolism in the liver. In most published work both are handled as lyophilized powders that are reconstituted for laboratory use.

Selank: a tuftsin-derived analog

Selank is a synthetic analog of tuftsin, a natural immunomodulatory tetrapeptide (threonine-lysine-proline-arginine) released from the Fc portion of immunoglobulin G. Its full sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, the tuftsin core extended by the stabilizing tail. Because tuftsin carries immune-signaling roles, research on Selank has spanned two areas at once. One line examines anxiolytic activity: preclinical models have looked at interactions with the GABAergic system, at modulation of enkephalin metabolism, and at changes in the expression of brain-derived signaling factors. A second line examines immunomodulatory effects, including influence on cytokine balance and interferon-related pathways. This combined profile, described in animal work as calming without the sedation associated with classical anxiolytics, is the feature most often highlighted in the literature.

Semax: an ACTH fragment analog

Semax derives from a different parent entirely. It is based on residues 4 to 10 of adrenocorticotropic hormone (ACTH), the fragment that carries behavioral and neurotrophic activity without the steroidogenic action of the full hormone. Its sequence is Met-Glu-His-Phe-Pro-Gly-Pro, again the active fragment plus the Pro-Gly-Pro tail. Research on Semax has concentrated on nootropic and neuroprotective questions. Preclinical studies have investigated its influence on brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) signaling, on the dopaminergic and serotonergic systems, and on markers of oxidative stress following ischemic injury. In its country of origin it has been examined in the context of cognitive and cerebrovascular research.

How the two compare

The clearest way to hold the pair apart is by parent molecule. Selank starts from an immune peptide, so its research story keeps returning to the crossover between mood-related and immune signaling. Semax starts from a neuroactive hormone fragment, so its research story is anchored in memory, attention, and protection of neural tissue under stress. Both are small, both are stabilized the same way, and both are studied by the same intranasal route, which is why they are so often mentioned in the same breath. Their targets and downstream pathways, though, only partly overlap, and treating them as interchangeable would miss the point of each design.

Handling and storage in the laboratory

As lyophilized powders, both peptides are generally kept cold and protected from light and moisture, with reconstituted material held under refrigeration and used within a limited window. For research measurement the concentration math is the same as for any other peptide: a known mass of powder is combined with a measured volume of solvent to produce a defined microgram-per-milliliter figure, which can then be read as volume on a graduated syringe. Both compounds, along with related nootropic research peptides such as cerebrolysin and the pineal peptides, can be compared side by side in the research catalog so that sequence, format, and certificate details are visible before a study is planned.

Research use only. This article is educational and is not medical, legal, or financial advice. The compounds discussed are not approved for human or veterinary use, consumption, or therapeutic application.